CT screening for lung cancer: Spiraling into confusion?

JAMA

Volumn 297, Issue 9, 2007, Pages 995-997

  Black, William C ^a,b   Baron, John A ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CAROTENE; PLACEBO; RETINOL;

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; EDITORIAL; HEALTH PROGRAM; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

EID: 33847701256     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.9.995     Document Type: Editorial

References (22)

1. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953-961.
2. Henschke CI, Yankelevitz DF, Libby DM, et al; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763-1771.
3. National Cancer Institute Web site. National Lung Screening Trial. http://www.cancer.gov/nlst. Accessed February 8, 2007.
4. Goldberg P. Lung screening advocates say verdict's in, attack NCI randomized trial as "outdated." Cancer Lett. 2006;32:1-7.
5. Ries LAG, Harkins D, Krapcho M, et al. National Cancer Institute Web site. SEER cancer statistics review, 1975-2003. http://seer.cancer.gov/csr/ 1975_2003/. Accessed February 8, 2007.
6. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235:259-265.
7. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95:470-478.
8. Omenn GS, Goodman G, Thornquist M, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res. 1994;54(suppl):2038s-2043s.
9. Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst. 2006;98:637-640.
10. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000;283:2975-2978.
11. Black WC. Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests. J Clin Oncol. 2006;24:3252-3260.
12. Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007;242:555-562.
13. Geddes DM. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest. 1979;73:1-17.
14. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst. 2000;92:1280-1282.
15. Chan CK, Wells CK, McFarlane MJ, et al. More lung cancer but better survival: implications of secular trends in "necropsy surprise" rates. Chest. 1989;96:291-296.
16. Dammas S, Patz EF Jr, Goodman PC. Identification of small lung nodules at autopsy: implications for lung cancer screening and overdiagnosis bias. Lung Cancer. 2001;33:11-16.
17. Li F, Sone S, Abe H, et al. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol. 2003;10:1013-1020.
18. Silvestri GA, Handy J, Lackland D, Corley E, Reed CE. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 1998;114:675-680.
19. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345:181-188.
20. Harpole DH Jr, DeCamp MM Jr, Daley J, et al. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg. 1999;117:969-979.
21. Stephan F, Boucheseiche S, Hollande J, et al. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest. 2000;118:1263-1270.
22. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007;120:868-874.